Automatic classification of dopamine transporter SPECT: deep convolutional neural networks can be trained to be robust with respect to variable image characteristics

This study investigated the potential of deep convolutional neural networks (CNN) for automatic classification of FP-CIT SPECT in multi-site or multi-camera settings with variable image characteristics. The study included FP-CIT SPECT of 645 subjects from the Parkinson’s Progression Marker Initiative (PPMI), 207 healthy controls, and 438 Parkinson’s disease patients. SPECT images were smoothed with an isotropic 18-mm Gaussian kernel resulting in 3 different PPMI settings: (i) original (unsmoothed), (ii) smoothed, and (iii) mixed setting comprising all original and all smoothed images. A deep CNN with 2,872,642 parameters was trained, validated, and tested separately for each setting using 10 random splits with 60/20/20% allocation to training/validation/test sample. The putaminal specific binding ratio (SBR) was computed using a standard anatomical ROI predefined in MNI space (AAL atlas) or using the hottest voxels (HV) analysis. Both SBR measures were trained (ROC analysis, Youden criterion) using the same random splits as for the CNN. CNN and SBR trained in the mixed PPMI setting were also tested in an independent sample from clinical routine patient care (149 with non-neurodegenerative and 149 with neurodegenerative parkinsonian syndrome). Both SBR measures performed worse in the mixed PPMI setting compared to the pure PPMI settings (e.g., AAL-SBR accuracy = 0.900 ± 0.029 in the mixed setting versus 0.957 ± 0.017 and 0.952 ± 0.015 in original and smoothed setting, both p < 0.01). In contrast, the CNN showed similar accuracy in all PPMI settings (0.967 ± 0.018, 0.972 ± 0.014, and 0.955 ± 0.009 in mixed, original, and smoothed setting). Similar results were obtained in the clinical sample. After training in the mixed PPMI setting, only the CNN provided acceptable performance in the clinical sample. These findings provide proof of concept that a deep CNN can be trained to be robust with respect to variable site-, camera-, or scan-specific image characteristics without a large loss of diagnostic accuracy compared with mono-site/mono-camera settings. We hypothesize that a single CNN can be used to support the interpretation of FP-CIT SPECT at many different sites using different acquisition hardware and/or reconstruction software with only minor harmonization of acquisition and reconstruction protocols.

[1]  Dong Young Lee,et al.  Adaptive template generation for amyloid PET using a deep learning approach , 2018, Human brain mapping.

[2]  Jan Booij,et al.  The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism , 2001, European Journal of Nuclear Medicine.

[3]  Kota Yokoyama,et al.  Computed-tomography-guided anatomic standardization for quantitative assessment of dopamine transporter SPECT , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  John Seibyl,et al.  SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0* , 2012, The Journal of Nuclear Medicine.

[5]  Mona Mustafa,et al.  Influence of movement on FP-CIT SPECT quantification: a Monte Carlo based simulation , 2007, Nuclear medicine communications.

[6]  Richard G. Baraniuk,et al.  A Probabilistic Framework for Deep Learning , 2016, NIPS.

[7]  Dinggang Shen,et al.  Deep auto-context convolutional neural networks for standard-dose PET image estimation from low-dose PET/MRI , 2017, Neurocomputing.

[8]  Peter Bartenstein,et al.  Radius dependence of FP-CIT quantification: a Monte Carlo-based simulation study , 2014, Annals of Nuclear Medicine.

[9]  Ayman El-Baz,et al.  Alzheimer's disease diagnostics by adaptation of 3D convolutional network , 2016, 2016 IEEE International Conference on Image Processing (ICIP).

[10]  Francisco Jesús Martínez-Murcia,et al.  Convolutional Neural Networks for Neuroimaging in Parkinson's Disease: Is Preprocessing Needed? , 2018, Int. J. Neural Syst..

[11]  Joaquim Salvi,et al.  One-shot domain adaptation in multiple sclerosis lesion segmentation using convolutional neural networks , 2018, NeuroImage: Clinical.

[12]  Francisco Jesús Martínez-Murcia,et al.  Using deep neural networks along with dimensionality reduction techniques to assist the diagnosis of neurodegenerative disorders , 2018, Log. J. IGPL.

[13]  Mirza Faisal Beg,et al.  Multiscale deep neural network based analysis of FDG‐PET images for the early diagnosis of Alzheimer's disease , 2018, Medical Image Anal..

[14]  A. McMillan,et al.  Deep learning Mr imaging–based attenuation correction for PeT/Mr imaging 1 , 2017 .

[15]  Seunggyun Ha,et al.  Refining diagnosis of Parkinson's disease with deep learning-based interpretation of dopamine transporter imaging , 2017, NeuroImage: Clinical.

[16]  Yiming Ding,et al.  A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain. , 2019, Radiology.

[17]  Dinggang Shen,et al.  3D conditional generative adversarial networks for high-quality PET image estimation at low dose , 2018, NeuroImage.

[18]  H Amthauer,et al.  Global scaling for semi-quantitative analysis in FP-CIT SPECT , 2014, Nuklearmedizin.

[19]  João Manuel R S Tavares,et al.  Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123I]FP-CIT SPECT images , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.

[21]  Kyong Hwan Jin,et al.  Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging , 2017, Behavioural Brain Research.

[22]  A. Singleton,et al.  The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.

[23]  J. Darcourt,et al.  Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  Dinggang Shen,et al.  Deep Learning Based Imaging Data Completion for Improved Brain Disease Diagnosis , 2014, MICCAI.

[25]  Claus Svarer,et al.  Reduction in camera-specific variability in [123I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  K. Tatsch,et al.  Quantitative approaches to dopaminergic brain imaging. , 2012, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[27]  Dinggang Shen,et al.  Effective feature learning and fusion of multimodality data using stage‐wise deep neural network for dementia diagnosis , 2018, Human brain mapping.

[28]  John O. Prior,et al.  Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study , 2018, PloS one.

[29]  K. Laere,et al.  European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[30]  Koen Van Laere,et al.  The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [123I]FP-CIT SPECT imaging , 2017, EJNMMI Research.

[31]  Osama Sabri,et al.  Value of Semiquantitative Analysis for Clinical Reporting of 123I-2-β-Carbomethoxy-3β-(4-Iodophenyl)-N-(3-Fluoropropyl)Nortropane SPECT Studies , 2013, The Journal of Nuclear Medicine.

[32]  Nico Karssemeijer,et al.  Transfer Learning for Domain Adaptation in MRI: Application in Brain Lesion Segmentation , 2017, MICCAI.

[33]  Wouter M. Kouw,et al.  MR Acquisition-Invariant Representation Learning , 2017, ArXiv.

[34]  Danni Cheng,et al.  Classification of Alzheimer’s Disease by Combination of Convolutional and Recurrent Neural Networks Using FDG-PET Images , 2018, Front. Neuroinform..

[35]  Jacques Darcourt,et al.  Implementation of the European multicentre database of healthy controls for [123I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[36]  N. De Stefano,et al.  Clinical use of brain volumetry , 2013, Journal of magnetic resonance imaging : JMRI.

[37]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[38]  Jacques Darcourt,et al.  Extrastriatal binding of [123I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[39]  Michael S. Bernstein,et al.  ImageNet Large Scale Visual Recognition Challenge , 2014, International Journal of Computer Vision.

[40]  Koen Van Laere,et al.  EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2 , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  Zuzana Walker,et al.  Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials , 2014, BMJ Open.

[42]  Nikolaos Karatzas,et al.  SPECT imaging evaluation in movement disorders: far beyond visual assessment , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[43]  Markus Nowak Lonsdale,et al.  Calibration of gamma camera systems for a multicentre European 123I-FP-CIT SPECT normal database , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[44]  Osama Sabri,et al.  Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  Sergey Ioffe,et al.  Rethinking the Inception Architecture for Computer Vision , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[46]  Michel Koole,et al.  [123I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods , 2017, EJNMMI Physics.

[47]  Wim Vandenberghe,et al.  The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[48]  Bram van Ginneken,et al.  A survey on deep learning in medical image analysis , 2017, Medical Image Anal..

[49]  Kenji Hirata,et al.  Convolutional neural network can help differentiate FDG PET images of brain tumor between glioblastoma and primary central nervous system lymphoma , 2016 .

[50]  Guigang Zhang,et al.  Deep Learning , 2016, Int. J. Semantic Comput..

[51]  Paras Lakhani,et al.  Diagnostic Performance of the Visual Reading of 123I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or Dementia , 2017, The Journal of Nuclear Medicine.

[52]  Jeffrey A. Fessler,et al.  Reducing between scanner differences in multi-center PET studies , 2009, NeuroImage.

[53]  Shihui Ying,et al.  Multimodal Neuroimaging Feature Learning With Multimodal Stacked Deep Polynomial Networks for Diagnosis of Alzheimer's Disease , 2018, IEEE Journal of Biomedical and Health Informatics.

[54]  Jens Kurth,et al.  CT-Based Attenuation Correction in I-123-Ioflupane SPECT , 2014, PloS one.

[55]  Robert B. Innis,et al.  Effect of scatter correction on the compartmental measurement of striatal and extrastriatal dopamine D2 receptors using [123I]epidepride SPET , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[56]  M. Thurston,et al.  Artificial intelligence in the diagnosis of Parkinson’s disease from ioflupane-123 single-photon emission computed tomography dopamine transporter scans using transfer learning , 2018, Nuclear medicine communications.

[57]  Jacques Darcourt,et al.  Individual-Reader Diagnostic Performance and Between-Reader Agreement in Assessment of Subjects with Parkinsonian Syndrome or Dementia Using 123I-Ioflupane Injection (DaTscan) Imaging , 2014, The Journal of Nuclear Medicine.

[58]  Klaus Tatsch,et al.  Nigrostriatal Dopamine Terminal Imaging with Dopamine Transporter SPECT: An Update , 2013, The Journal of Nuclear Medicine.

[59]  Anders M. Dale,et al.  Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.